Court approves pSvida re-incorporation

By Dylan Bushell-Embling
Wednesday, 11 June, 2008

WA biotech pSvida (ASX: PSD) has received court approval to re-incorporate in the US, paving the way for the company to be re-listed on the NASDAQ stock exchange.

The company announced yesterday that the Federal Court of Australia had approved its reincorporation proposals.

The reincorporation will take effect today, and pSvida shares will start trading on NASDAQ starting today or Thursday.

As part of the process, pSvida will cease trading shares on the ASX, and won't resume full ASX trading until June 26.

pSvida will also begin trading on the Frankfurt Stock Exchange on Thursday.

Content from other channels on our network

Mitigating unseen losses in large food packs

Perfect Automation and Omori have joined forces with packaging solutions

Fonterra names Richard Allen as new CEO

Food packaging testing supports Atlantic crossing victory

Seprify and BIOGRUND develop titanium dioxide-free tablet coating for nutraceuticals

National Pain Alliance launched to advocate for chronic pain

Sexual misconduct findings added to public register under "landmark reforms"

Australia invests further $14.6 million in national allergy research

Can seasonal influenza vaccination prime the immune system for future strains?

"Targeted supports" launched for former patients of Simon Gordon

Ensuring reliable level measurement in tanks with internal obstructions

Australia and US investing in additional critical minerals projects

How to centralise remote access: securing all access to your OT systems

Shining a light on cyber threats hiding on the plant floor

AI system learns to keep warehouse robot traffic running smoothly

Court approves pSvida re-incorporation

Proposed Australian trial eyes up blood testing for Alzheimer's

Applications open for $300K pandemic therapeutics fellowships

CTA granted for CAR-T cell therapy for multiple myeloma

Content from other channels on our network